Huons Co., Ltd. (KOSDAQ:243070)

Market Cap	343.70B
Revenue (ttm)	595.36B
Net Income (ttm)	34.97B
Shares Out	11.65M
EPS (ttm)	2,909.22
PE Ratio	10.14
Forward PE	n/a
Dividend	630.00 (2.13%)
Ex-Dividend Date	Aug 20, 2025

Volume	21,461
Average Volume	30,452
Open	29,700
Previous Close	29,600
Day's Range	29,250 - 29,750
52-Week Range	21,800 - 32,200
Beta	0.14
RSI	41.50
Earnings Date	Nov 9, 2025

About Huons

Huons Co., Ltd. provides medical solutions for human health in Korea and internationally. The company offers oral solid form drugs, including circulatory system, metabolic, antipyretic, analgesic, anti-inflammatory, musculoskeletal system, digestive system, antihistamine, respiratory system, antibiotic, well-being, urogenital system, and other chemotherapeutic products; and injection products, such as anesthetic, antipyretic, analgesic, anti-inflammatory, skeletal muscle relaxant, antispasmodic, antihistamine, circulatory system, respiratory sy...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1965
• Employees: 912
• Stock Exchange: KOSDAQ
• Ticker Symbol: 243070

Financial Performance

In 2024, Huons's revenue was 590.23 billion, an increase of 6.92% compared to the previous year's 552.01 billion. Earnings were 29.45 billion, a decrease of -41.64%.